Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1593 studies found for:    HIV OR AIDS | Open Studies | NIH
Show Display Options
RSS Create an RSS feed from your search for:
HIV OR AIDS | Open Studies | NIH
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
Condition: HIV
Intervention:
2 Recruiting Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Conditions: HIV Infections;   Cardiovascular Diseases
Interventions: Drug: Pitavastatin;   Drug: Placebo
3 Recruiting Brain Imaging for HIV-Associated Thinking and Mood Disorders
Conditions: Human Immunodeficiency Virus;   Neurocognitive Impairment
Intervention:
4 Recruiting Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Condition: HIV Infections
Interventions: Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
5 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Condition: HIV
Interventions: Drug: Ritonavir;   Drug: Cobicistat
6 Recruiting Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
Condition: HIV/AIDS
Intervention:
7 Recruiting Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART)
Condition: HIV
Interventions: Other: Universal Testing with immediate ART;   Other: Universal Testing with ART eligibility according to National Guidelines;   Other: Standard of Care
8 Recruiting Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
Conditions: Acute HIV Infection;   Antiretroviral Treatment Interruption
Intervention: Other: Treatment interruption
9 Recruiting Reducing Proviral HIV DNA With Interferon-a
Conditions: HIV;   HIV/AIDS
Intervention: Drug: Peg-IFN-α2b
10 Recruiting EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Condition: Pregnancy Related
Intervention:
11 Recruiting Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations
Condition: HIV Infection
Intervention: Behavioral: Integrated care centers
12 Not yet recruiting Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205
Condition: HIV Infections
Interventions: Biological: MVA/HIV62B vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo
13 Recruiting Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Telmisartan
14 Recruiting Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
Condition: HIV
Intervention: Biological: HXTC infusion
15 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
16 Unknown  Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
Condition: HIV Infections
Intervention: Biological: SCBaL/M9
17 Recruiting IMPAACT P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission
Condition: HIV Infection
Intervention: Drug: Intensive ART regimen
18 Recruiting Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption
Condition: HIV
Intervention: Biological: Entyvio (Vedolizumab)
19 Recruiting HIV Risk and Prevention in Women
Condition: HIV
Interventions: Behavioral: Opt-in or Opt-out testing;   Behavioral: Focus Group
20 Recruiting Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: Placebo for VRC01

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years